Tinklalapis: www.alvogen.com
Aprašymas: Alvogen is the next generation pharmaceuticals company. Our business model ensures competitive advantage through focused in-house capabilities and a network of partners for enhanced speed and flexibility. Alvogen currently has commercial operations in 34 countries around the globe, with regional hubs based in North America, Romania and Taiwan.
Tekstinė tinklalapio versija: History Milestones on our journey Well targeted portfolio Worldwide Offices Citizenship Products International pharmaceutical company Follow us A unique portfolio of high quality and difficult-to-make pharmaceutical products fuels our targeted growth strategy. Alvogen has over 200 strategically selected pharmaceutical projects in development and registrations and 350 marketed products. The group’s product portfolio consists of a broad range of leading molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. Alvogen also sells and markets a growing portfolio of OTC medicines. Partnerships Company Alvogen scores high at CPhI 2014 Building young lives Leadership team Newsroom Alvogen has commercial operations in more than 30 countries around the globe. The company has an innate passion for performance and growth and has become a major player driving change in this ever-changing industry. Our [..]